Last updated on December 2019

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)


Brief description of study

The aim of the study is to investigate the safety and efficacy of empagliflozin versus placebo on top of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.

Clinical Study Identifier: NCT03057977

Find a site near you

Start Over

Urasoe General Hospital

Okinawa, Urasoe, Japan
0.78miles
  Connect »

Naha City Hospital

Okinawa, Naha, Japan
1.51miles
  Connect »

Nanbu Tokushukai Hospital

Okinawa, Shimajiri-gun, Japan
4.72miles
  Connect »